Friday, March 29, 2024 11:44:37 AM
Agree 100%. Personally, I think ZIVO is just 1 mistake after another. This one ..... going dark after the completion and positive results for the final coccidiosis trial.
There's no doubt in my mind Payne is talking to big animal pharma. How many ... dunno, but what I do know is he has personal history with at least 2 of them. Those who actually take the time to look know this. But IMO silence isn't the answer on multiple fronts.
Chart .... yep ... unless it bounces back here above 8.50 it's broke. Again. There was a new bidder end of week for 5K shares at 6.80. Strange to me given the silence but legit bid nonetheless.
Yep ZIVO typical 15 minutes of excitement 364 days of "payne". Pun intended.
Yaldoo still owns a ton. But IMO is a zero outside of his money. And agree 3 guys are holding close to 50% of the stock. And I'm 99% certain there are others close to them that own more. For instance I believe latest Maggiore filings indicated no longer included shares of his brother in laws estate that I'm pretty sure werent sold.
The 10k has a note about a $500k loan on March 5th at 8.5%. Hidden on very last page of 10K. So they have gotten money recently. Of course that's not going to last long and certainly need more. And that is part reason the silence is a problem in my book. I can understand there could certainly be some sensitive discussions happening. And ZIVO has no leverage. But the test results in my book provide the opportunity to create leverage and generate interest to the financial benefit of the company and investors. IMO Payne is more or less part of what I'd call the "establishment" that does things a certain way. He's been the CEO of one of these animal pharmas and is still heavily involved in animal businesses with contacts to all these pharmas. So I can see how not wanting to "rock the boat" might be his style. Whereas a new age CEO might be plastering the results everywhere and doing things completely different.
Bottomline is none of this stuff happens fast in pharma. Clearly at least 1 pharma was in on the original test that was botched. So no doubt in my mind that pharma is still there. My question is who else is in on it? Leverage works wonders for better deal.
Timeline is also a problem. Who knows when ? Nobody knows. So ... ya either own it or ya don't. And patience and balls of steel are required.
I am still standing pat on my swing trade from 60 cents. I am admittedly breaking my own trading rules and hard to sit on such a large gain ..... however I did post my sale to cover costs. So letting it ride for the time being. And ideally would rather a large gain like this fall into LTCG category too but long way to go for that . =)
Amigo Mike
Recent ZIVO News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 05:36:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 12:05:12 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/09/2024 03:49:14 PM
- Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/14/2024 01:16:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:37 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 02/15/2024 01:54:37 PM
- ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study • Business Wire • 02/07/2024 09:54:00 PM
- ZIVO Bioscience Announces Uplisting to OTCQB Market • Business Wire • 01/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:11:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:17:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:23:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:12:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 02:29:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:21:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:18:41 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 10/30/2023 05:20:31 PM
- ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens • Business Wire • 10/30/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 12:56:59 PM
- ZIVO Bioscience Announces Reverse Stock Split • Business Wire • 10/26/2023 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/04/2023 09:08:51 PM
- ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference • GlobeNewswire Inc. • 10/03/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM